News
-
20 January 2021
NIH to enter Phase II of Covid-19 biomarker development contract
The National Institutes of Health (NIH) unit National Cancer Institute (NCI) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) are set to enter Phase II of a multi-phase...
-
18 January 2021
US scientists develop blood test for high-risk Covid-19 patients
Scientists at Washington University School of Medicine in St Louis, US, have developed a new simple and rapid test that can measure mitochondrial DNA in the blood of a Covid-19...
-
15 January 2021
UK MHRA authorises integrated imaging technology for Covid-19
The UK Medicines & Healthcare products Regulatory Agency (MHRA) has approved the use of Perspectum’s magnetic resonance imaging (MRI)-based technology, CoverScan MD, for mapping the effects of Covid-19 on various...
-
15 January 2021
PerkinElmer’s Covid-19 assay granted FDA EUA for asymptomatic testing
The US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) to PerkinElmer’s Covid-19 RT-PCR assay to test individuals without symptoms.
-
13 January 2021
FDA grants EUA to MatMaCorp’s Covid-19 test and Ortho’s antigen test
The US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) to MatMaCorp’s Covid-19 2SF RNA test for SARS-CoV-2 detection on its Solas 8 portable detection system.
-
13 January 2021
UK approves Excalibur’s Covid-19 antigen test for mass screening
The UK Medicines & Healthcare Products Regulatory Agency (MHRA) has approved Excalibur Healthcare Services’ lateral flow antigen test for mass screening for Covid-19 in asymptomatic, pre-symptomatic, and symptomatic people.
-
12 January 2021
CovidDeep app 90% accurate at predicting coronavirus infection
Princeton University spinout NeuTigers has launched a rapid screening app that uses wearable sensor data to triage patients who may be suffering from Covid-19.
-
11 January 2021
US FDA lists Applied DNA Sciences’ Covid-19 test for virus detection
The US Food and Drug Administration (FDA) has published a safety communication that identifies Applied DNA Sciences’ Linea COVID-19 Assay Kit as one of only two tests marketed under its...
-
8 January 2021
Spectrum and Steribottle partner for saliva-based Covid-19 testing
Spectrum Solutions and Steribottle have partnered for the Covid-19 population testing directive in the UK that integrates the former’s SDNA-1000 Saliva Collection Device.
-
8 January 2021
ForaCare Suisse introduces diagnostic antigen test for Covid-19
ForaCare Suisse has released its FORA COVID-19 Antigen Rapid Test, which can deliver quick, precise, and easy-to-interpret test results in 15 minutes.